Publications

Selected Publications

  1. Devaud N, Vornicova O, Abdul Razak AR, Khalili K, Demicco EG, Mitric C, Bernardini MQ, Gladdy RA. Leiomyosarcoma: Current Clinical Management and Future Horizons. Surg Oncol Clin N Am. 2022 Jul; 31(3):527-546.
  2. Guram S, Covelli AM, O’Neill AC, Shultz DB, Demicco EG, Gupta AA, Gladdy RA. Multidisciplinary Intervention in Radiation-Induced Angiosarcoma of the Breast: Patterns of Recurrence and Response to Treatment. Ann Surg Oncol. 2022 Jan; 29(1):522-532.
  3. Ng D, Cyr DP, Burtenshaw SM, Callegaro D, Gronchi A, Shultz D, Brar S, Chung P, Gladdy RA, Catton C, Swallow CJ. Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma. Ann Surg Oncol. 2022 Apr; 29(4):2304-2314. 
  4. McKinnon T, Venier R, Yohe M, Sindiri S, Gryder B, Shern J, Kabaroff L, Dickson B, Schleicher K, Chouinard-Pelletier G, Menezes S, Gupta A, Zhang X, Guha R, Ferrer M, Thomas C, Wei Y, Davani D, Guidos CJ, Khan J, Gladdy RA. Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma. Oncogene. 2018 Feb 28; 37(20):2630-2644.
  5. Gervais MK, Burtenshaw SM, Maxwell J, Dickson BC, Catton CN, Blackstein M, McCready D, Escallon J, Gladdy RA. Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges. J Surg Oncology. 2017 Dec; 116(8):1056-1061.
  6. Burtenshaw SM, Cannell AJ, McAlister ED, Siddique S, Kandel R, Blackstein ME, Swallow CJ, Gladdy RA. Toward observation as first-line management in abdominal desmoid tumors. Ann Surg Oncol. 2016 Jul 1; 23(7):2212-9. With Editorial by van Broekhoven DL, Grunhagen DJ, Verhoef C, Ann Surg Oncol.
  7. Babichev Y, Kabaroff L, Datti A, Uehling D, Isaac M, Al-Awar R, Prakesch M, Sun RX, Boutros PC, Venier R, Dickson BC, Gladdy RA. PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma. J Transl Med. 2016 Mar 8; 14:67.
  8. McKinnon T, Venier R, Dickson BC, Kabaroff L, Alkema M, Chen L, Shern JF, Yohe ME, Khan J, Gladdy RA. Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation. Oncotarget. 2015 Jun 10; 6(16):14220-14232.
  9. Kabaroff L, Gupta A, Menezes S, Babichev Y, Kandel RC, Swallow CJ, Dickson BC, Gladdy RA. Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene delivery. PLoS One. 2014 Apr; 9(4):e94817.
  10. Gladdy RA, Qin LX, Moraco N, Agaram NP, Brennan MF, Singer S. Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol. 2013 Jun 1; 20(6):1851-7.
  11. Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, Brennan MF, Singer S. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010 Apr 20; 28(12):2064-9.

Pubmed

Google Scholar
   Our Team Contact/Apply